• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国疫苗管理体制改革——基于新治理视角的分析

Reforms in China's Vaccine Administration-From the Perspective of New Governance Approach.

机构信息

KoGuan School of Law, China Institute for Smart Court, Shanghai Jiao Tong University, Shanghai 200030, China.

出版信息

Int J Environ Res Public Health. 2023 Feb 16;20(4):3450. doi: 10.3390/ijerph20043450.

DOI:10.3390/ijerph20043450
PMID:36834145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9966921/
Abstract

Recent vaccine scandals have overshadowed China's accomplishments in public health, triggering discussions on the causes of vaccine incidents. This study aims to review the development of China's vaccine administration, find out the causes of recurring vaccine incidents in the past decades, and propose a new governance approach to vaccine administration in the context of a public resource trading system. We collect and analyze relevant legal frameworks and data from legislative materials, government documents, press releases, and reports from the World Health Organization. In essence, it is the combination of the lagging legal system and the absence of information technology infrastructure in the process of vaccine administration reform that has led to the recurrence of vaccine incidents. Though the vaccine incidents occurred concentratedly in phases of production and lot release, and circulation, it is necessary to examine the whole life cycle of vaccine administration. The enactment of the Vaccine Administration Law outlines a supervision framework, which utilizes the Whole Process Electronic Traceability System and Whole Life-cycle Quality Management System to achieve the interconnection of all aspects of vaccine administration. The reform of China's vaccine administration is essentially a balance between efficiency and safety, which also represents the interaction between marketization and administrative supervision.

摘要

近期的疫苗丑闻给中国的公共卫生成就蒙上了阴影,引发了对疫苗事件原因的讨论。本研究旨在回顾中国疫苗管理的发展历程,找出过去几十年疫苗事件反复发生的原因,并在公共资源交易体系背景下提出疫苗管理的新治理方法。我们收集并分析了立法材料、政府文件、新闻稿和世界卫生组织报告中的相关法律框架和数据。从本质上讲,疫苗管理改革过程中滞后的法律体系和缺乏信息技术基础设施导致了疫苗事件的反复发生。虽然疫苗事件集中发生在生产和批次放行以及流通阶段,但有必要对疫苗管理的整个生命周期进行审查。《疫苗管理法》的颁布勾勒出一个监督框架,利用全过程电子追溯系统和全生命周期质量管理体系实现疫苗管理各个方面的互联。中国疫苗管理的改革本质上是在效率和安全之间取得平衡,这也代表了市场化和行政监督之间的互动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/a4026849aee4/ijerph-20-03450-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/287e1ef92456/ijerph-20-03450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/2208d8631565/ijerph-20-03450-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/a4026849aee4/ijerph-20-03450-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/287e1ef92456/ijerph-20-03450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/2208d8631565/ijerph-20-03450-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/905e/9966921/a4026849aee4/ijerph-20-03450-g003.jpg

相似文献

1
Reforms in China's Vaccine Administration-From the Perspective of New Governance Approach.中国疫苗管理体制改革——基于新治理视角的分析
Int J Environ Res Public Health. 2023 Feb 16;20(4):3450. doi: 10.3390/ijerph20043450.
2
China's Vaccine Diplomacy and Its Implications for Global Health Governance.中国的疫苗外交及其对全球卫生治理的影响。
Healthcare (Basel). 2022 Jul 10;10(7):1276. doi: 10.3390/healthcare10071276.
3
The development of China's vaccine industry in the past decade: the perspective from drug regulatory science.中国疫苗行业十年来的发展:从药品监管科学的角度。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5666-5672. doi: 10.1080/21645515.2021.2002640.
4
How to ensure vaccine safety: An evaluation of China's vaccine regulation system.如何确保疫苗安全:对中国疫苗监管体系的评估。
Vaccine. 2021 Aug 31;39(37):5285-5294. doi: 10.1016/j.vaccine.2021.07.081. Epub 2021 Aug 6.
5
The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.医疗大数据对中国商业健康保险行业的挑战:评估与建议。
BMC Health Serv Res. 2022 Sep 22;22(1):1189. doi: 10.1186/s12913-022-08574-2.
6
Expanding public health in China: an empirical analysis of healthcare inputs and outputs.中国公共卫生的扩展:医疗投入与产出的实证分析。
Public Health. 2017 Jan;142:73-84. doi: 10.1016/j.puhe.2016.10.007. Epub 2016 Nov 22.
7
Understanding China's growing involvement in global health and managing processes of change.了解中国在全球卫生领域日益增加的参与度以及管理变革进程。
Global Health. 2020 May 1;16(1):39. doi: 10.1186/s12992-020-00569-0.
8
Medical Insurance Information Systems in China: Mixed Methods Study.中国医疗保险信息系统:混合方法研究
JMIR Med Inform. 2020 Sep 1;8(9):e18780. doi: 10.2196/18780.
9
The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.中国疫情防控期间的法律制度对公共卫生和生活质量的影响:一项实证研究。
Int J Environ Res Public Health. 2022 Oct 20;19(20):13598. doi: 10.3390/ijerph192013598.
10
Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.让地方政府参与解决健康公平问题:中国卫生系统改革中的挑战与机遇
Health Policy Plan. 2013 Dec;28(8):809-24. doi: 10.1093/heapol/czs120. Epub 2012 Dec 4.

本文引用的文献

1
Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese Scholarship.应对中国的疫苗犹豫问题:对中国学术研究的范围综述
Vaccines (Basel). 2019 Dec 20;8(1):2. doi: 10.3390/vaccines8010002.
2
Vaccine scandal and crisis in public confidence in China.中国的疫苗丑闻与公众信心危机。
Lancet. 2016 Jun 11;387(10036):2382. doi: 10.1016/S0140-6736(16)30737-1.
3
Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.媒体报道中国婴儿乙肝疫苗接种后死亡事件后,公众对疫苗失去信心。
Int J Epidemiol. 2016 Apr;45(2):441-9. doi: 10.1093/ije/dyv349.
4
Two decades of battle against polio: opening a window to examine public health in China.二十载抗击脊髓灰质炎:打开一扇窗,审视中国公共卫生事业
Int J Infect Dis. 2010 Sep;14 Suppl 3:e9-e13. doi: 10.1016/j.ijid.2010.02.2252. Epub 2010 Jun 29.
5
The consistency approach for the quality control of vaccines.疫苗质量控制的一致性方法。
Biologicals. 2008 Jan;36(1):73-7. doi: 10.1016/j.biologicals.2007.05.002. Epub 2007 Sep 24.